NCT01601470 - Evaluation of Drug-drug Interaction Between LCZ696 and Sildenafil in Subjects With Mild to Moderate Hypertension | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Mild to Moderate Hypertension

Interventions

DRUG

LCZ696

LCZ696 400mg QD was administered alone for 4 days and in combination with sildenafil for 1 day

DRUG

Sildenafil

Sildenafil 50 mg single dose was administered alone for 1 days and in combination with LCZ696 400mg QD for 1 day

Trial Locations (1)

Novartis Investigative Site, Berlin